Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study.
Fumihiko SakaiNorihiro SuzukiXiaoping NingMiki IshidaChiharu UsukiKatsuhiro IbaYuki IsogaiNobuyuki KogaPublished in: Drug safety (2021)
ClinicalTrials.gov Identifier: NCT03303105.